SSRI

SSRIs Are Expensive Placebos? The Harvard Study Big Pharma Doesn't Want You to See

For the last 30 years, a multi-billion dollar industry sold the world a profound lie about the chemical imbalance theory and depression. Today on Sober Psychology, we're putting Big Pharma on the operating table to expose the medicalization of normal human suffering and reveal the hard-hitting truth about SSRIs. We dive deep into the clinical data, including the 2022 University College London umbrella review and Dr. Irving Kirsch’s Harvard placebo study , to explore how these medications often function as incredibly expensive, side-effect-heavy placebos. This episode aggressively dissects the insidious expansion of the DSM-5 , the horrific reality of Akathisia , the FDA black box warnings regarding suicidal ideation , and the pediatric pipeline that is currently fueling the ADHD stimulant epidemic in young children. Finally, we tackle the spiritual cost of numbing your brain—the modern form of Pharmakeia —and provide three critical rules to safely build distress tolerance, alter your environment, and get your life back without relying on a chemical fix. Disclaimer: I am a psychologist in training, not a psychiatrist. Do not abruptly stop taking your psychiatric medication; always work with a medical professional to safely and slowly taper off.